ARP Americas LP bought a new stake in Exponent, Inc. (NASDAQ:EXPO) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 3,400 shares of the business services provider’s stock, valued at approximately $275,000.
A number of other institutional investors also recently modified their holdings of EXPO. Goldman Sachs Group Inc. grew its position in shares of Exponent by 6.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 148,449 shares of the business services provider’s stock valued at $10,244,000 after purchasing an additional 8,426 shares during the last quarter. Cubist Systematic Strategies LLC grew its position in shares of Exponent by 138.8% in the fourth quarter. Cubist Systematic Strategies LLC now owns 14,383 shares of the business services provider’s stock valued at $993,000 after purchasing an additional 8,361 shares during the last quarter. Mason Street Advisors LLC grew its position in shares of Exponent by 2.4% in the fourth quarter. Mason Street Advisors LLC now owns 18,052 shares of the business services provider’s stock valued at $1,246,000 after purchasing an additional 423 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Exponent by 3.9% in the fourth quarter. Geode Capital Management LLC now owns 828,673 shares of the business services provider’s stock valued at $57,186,000 after purchasing an additional 31,065 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Exponent in the fourth quarter valued at approximately $40,212,000. 88.81% of the stock is owned by institutional investors.
EXPO has been the topic of several research reports. BidaskClub upgraded shares of Exponent from a “hold” rating to a “buy” rating in a research report on Saturday. Zacks Investment Research lowered shares of Exponent from a “hold” rating to a “sell” rating in a research report on Friday, July 3rd. Finally, Sidoti raised their target price on shares of Exponent from $80.00 to $94.00 and gave the stock a “buy” rating in a research report on Tuesday, June 2nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. Exponent presently has a consensus rating of “Hold” and a consensus target price of $86.75.
NASDAQ EXPO traded up $0.61 during mid-day trading on Friday, reaching $84.06. 420,743 shares of the stock were exchanged, compared to its average volume of 186,028. Exponent, Inc. has a 1-year low of $58.03 and a 1-year high of $84.34. The business’s fifty day simple moving average is $78.81 and its 200 day simple moving average is $73.63. The stock has a market capitalization of $4.33 billion, a PE ratio of 55.30 and a beta of 0.26. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.81 and a current ratio of 3.81.
Exponent (NASDAQ:EXPO) last announced its earnings results on Thursday, July 30th. The business services provider reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.09. Exponent had a net margin of 19.87% and a return on equity of 23.68%. The firm had revenue of $87.86 million for the quarter, compared to analyst estimates of $85.11 million. On average, analysts anticipate that Exponent, Inc. will post 1.33 EPS for the current year.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Featured Story: Compound Interest and Why It Matters When Investing
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.